Back to Search
Start Over
Effects of protease activated receptor (PAR)2 blocking peptide on endothelin-1 levels in kidney tissues in endotoxemic rat mode.
- Source :
-
Life sciences [Life Sci] 2014 May 02; Vol. 102 (2), pp. 127-33. Date of Electronic Publication: 2014 Mar 16. - Publication Year :
- 2014
-
Abstract
- Aims: Septic shock, the severe form of sepsis, is associated with development of progressive damage in multiple organs. Kidney can be injured and its functions altered by activation of coagulation, vasoactive-peptide and inflammatory processes in sepsis. Endothelin (ET)-1, a potent vasoconstrictor, is implicated in the pathogenesis of sepsis and its complications. Protease-activated receptors (PARs) are shown to play an important role in the interplay between inflammation and coagulation. We examined the time-dependent alterations of ET-1 and inflammatory cytokine, such as tumor necrosis factor (TNF)-α in kidney tissue in lipopolysaccharide (LPS)-induced septic rat model and the effects of PAR2 blocking peptide on the LPS-induced elevations of renal ET-1 and TNF-α levels.<br />Main Methods: Male Wistar rats at 8 weeks of age were administered with either saline solution or LPS at different time points (1, 3, 6 and 10h). Additionally, we treated LPS-administered rats with PAR2 blocking peptide for 3h to assess whether blockade of PAR2 has a regulatory role on the ET-1 level in septic kidney.<br />Key Findings: An increase in ET-1 peptide level was observed in kidney tissue after LPS administration time-dependently. Levels of renal TNF-α peaked (around 12-fold) at 1h of sepsis. Interestingly, PAR2 blocking peptide normalized the LPS-induced elevations of renal ET-1 and TNF-α levels.<br />Significance: The present study reveals a distinct chronological expression of ET-1 and TNF-α in LPS-administered renal tissues and that blockade of PAR2 may play a crucial role in treating renal injury, via normalization of inflammation, coagulation and vaso-active peptide.<br /> (Copyright © 2014 Elsevier Inc. All rights reserved.)
- Subjects :
- Animals
Endothelin-1 antagonists & inhibitors
Endothelin-1 metabolism
Endotoxemia chemically induced
Endotoxemia drug therapy
Kidney Diseases chemically induced
Kidney Diseases drug therapy
Lipopolysaccharides administration & dosage
Male
Peptide Fragments therapeutic use
Rats
Rats, Wistar
Treatment Outcome
Tumor Necrosis Factor-alpha metabolism
Disease Models, Animal
Endothelin-1 biosynthesis
Endotoxemia metabolism
Kidney Diseases metabolism
Peptide Fragments pharmacology
Receptor, PAR-2 antagonists & inhibitors
Receptor, PAR-2 metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1879-0631
- Volume :
- 102
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Life sciences
- Publication Type :
- Academic Journal
- Accession number :
- 24641950
- Full Text :
- https://doi.org/10.1016/j.lfs.2014.03.013